FDA announces new Drug Safety Initiative. So what’s next?

Here at SRxA we’re thrilled to hear that the FDA is exploring the use of cutting-edge technology to help study and better understand adverse events.  Last week, Biovista Inc, announced that the FDA has licensed its advanced technology platform that is able to cross-correlate thousands of adverse events against any drug or combination therapy.  Ultimately, it’s hoped that this technology will enable physicians to predict which patients are likely to suffer side effects from a particular drug and thus make prescribing safer for patients.

After embracing this space-age technology we hope that the Agency will soon come to a decision about other  space-age media.  You, our readers, may have already heard of them: the Internet, the Blogosphere and Social Media!

Our team of certified Social Media Strategists is standing by!

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s